Dr. Hellmann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-3052Fax+1 410-550-1033
Education & Training
- University of California (San Francisco)Fellowship, Rheumatology, 1982
- Johns Hopkins UniversityResidency, Internal Medicine, 1977 - 1980
- Johns Hopkins University School of MedicineClass of 1977
Certifications & Licensure
- CA State Medical License 1980 - Present
- FL State Medical License 2020 - Present
- MD State Medical License 1986 - 2026
- NH State Medical License 2024 - 2024
- NC State Medical License 2020 - 2022
- ME State Medical License 2020 - 2021
- AL State Medical License 2020 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
- Join now to see all
Publications & Presentations
PubMed
- 167 citationsEtanercept combined with conventional treatment in Wegener's granulomatosis: A six-month open-label trial to evaluate safetyJohn H. Stone, Misty L. Uhlfelder, David B. Hellmann, Sonya Crook, Nita Marie Bedocs
Arthritis and Rheumatism. 2001-05-01 - 350 citationsA multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.Gary S. Hoffman, Maria C. Cid, David B. Hellmann, Loïc Guillevin, John H. Stone
Arthritis and Rheumatism. 2002-05-01 - 55 citationsA pilot study of peer review in residency trainingPatricia A. Thomas, Kelly A. Gebo, David B. Hellmann
Journal of General Internal Medicine. 1999-09-01
Press Mentions
- CV Drugs Not Linked to Poor Outcomes in Patients at High Risk for COVID-19August 9th, 2021
- Hellmann to Step down as Chairman of the DOM at JHBMCJune 19th, 2020
Professional Memberships
- Fellow
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/david-hellmann
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: